Open original FDA record ↗Recall record
- FDA identifier
- Z-2170-2014
- Company in FDA record
- Nanosphere, Inc.
- FDA classification date
- Aug 8, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Nanosphere has determined that a portion of BC-GN Test Cartridge Lot number 040214021A has an elevated risk for No Call results and False Negative results. The BC-GN Test Cartridge (20-006-021) is distributed as part of the Verigene BC-GN Test Kit (20-005-021), which is labeled as "IVD". Therefore, Nanosphere has initiated a voluntary recall to retrieve the following BC-GN Test Cartridges: Test Ca
Source facts
- Action
- All customers were initially notified of the recall by telephone on April 17, 2014. The customers were instructed to quarantine and return all affected product to Nanosphere. Nanosphere sent an Voluntary Product Recall Notification letter dated April 17, 2014, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. The letters included instructions: 1) on how to return the recalled products, and 2) to review any test results that were generated while using the recalled products to ensure that there has been no negative impact on patient care. Customers with questions can contact Nanosphere at 888-837-4436, option 2 or via e-mail at Technicalsupport@nanosphere.us..
- Initiated
- 2014-04-17
- Root cause
- Under Investigation by firm
- Terminated
- 2016-03-14
- Distribution
- US Distribution including the states of AZ, CA, FL, MN, MT, NE, NJ, NY, TX and WI
- Recall number
- Z-2170-2014
- Recall status
- Terminated
- CDRH record ID
- 127104
- FDA classified
- 2014-08-08
- Recall event number
- 68177